Stock & Company Details
CytoMed Therapeutics Ltd $GDTC
Price:
N/A
N/A
12M
$11M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.63
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GDTC technical indicators
Latest CytoMed Therapeutics Ltd (GDTC) indicator readings as of 2026-10-29.
GDTC's 14-day RSI is 49.7, in neutral territory. At $0.90 it is trading 8.4% below its 200-day moving average of $0.98, and below its 50-day average of $0.90. Price sits in the middle of its Bollinger Bands ($0.82 to $0.99). ADX reads 16.1, indicating a range-bound market rather than a trend.
Overview
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is majority revenue generator.
Finance Bot
Ask your questions
Start by typing a question below.
